StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.25−0.03 (-9.88%)

Close on Nov 18, 2026Market cap $5.50MP/E –Yield –

Soligenix operating margin

Operating margin is operating income as a percentage of revenue.

Soligenix's operating margin for the twelve months ending Dec 31, 2024 was -7907.7%. For fiscal 2024 it was -7907.7%, against -917.1% the year before. The highest annual figure on record is -38.6% in fiscal 2011.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-7907.7%−6990.6
FY2023Dec 31, 2023-917.1%+583.4
FY2022Dec 31, 2022-1500.6%+88.6
FY2021Dec 31, 2021-1589.2%−801.4
FY2020Dec 31, 2020-787.7%−560.1
FY2019Dec 31, 2019-227.7%−54.8
FY2018Dec 31, 2018-172.8%−33.0
FY2017Dec 31, 2017-139.8%−85.1
FY2016Dec 31, 2016-54.6%+26.4
FY2015Dec 31, 2015-81.1%+71.7
FY2014Dec 31, 2014-152.8%+69.2
FY2013Dec 31, 2013-222.0%−72.8
FY2012Dec 31, 2012-149.2%−110.5
FY2011Dec 31, 2011-38.6%+365.9
FY2010Dec 31, 2010-404.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-74495.1%−73707.2
Q1 FY2024Mar 31, 2024-1809.0%−972.8
Q4 FY2023Dec 31, 2023-873.3%+102.0
Q3 FY2023Sep 30, 2023-1363.9%+490.7
Q2 FY2023Jun 30, 2023-787.9%+697.1
Q1 FY2023Mar 31, 2023-836.3%+1393.0
Q4 FY2022Dec 31, 2022-975.2%+661.5
Q3 FY2022Sep 30, 2022-1854.6%−47.4
Q2 FY2022Jun 30, 2022-1485.0%−93.8
Q1 FY2022Mar 31, 2022-2229.2%−715.9
Q4 FY2021Dec 31, 2021-1636.8%+73.4
Q3 FY2021Sep 30, 2021-1807.2%−1509.4
Q2 FY2021Jun 30, 2021-1391.2%−834.3
Q1 FY2021Mar 31, 2021-1513.4%−596.8
Q4 FY2020Dec 31, 2020-1710.2%−1509.2
Q3 FY2020Sep 30, 2020-297.8%+13.3
Q2 FY2020Jun 30, 2020-556.9%−418.0
Q1 FY2020Mar 31, 2020-916.5%−824.4
Q1 FY2019Mar 31, 2019-200.9%+12.9
Q4 FY2018Dec 31, 2018-311.1%−111.7
Q3 FY2018Sep 30, 2018-138.9%−85.7
Q2 FY2018Jun 30, 2018-92.1%+141.7
Q1 FY2018Mar 31, 2018-213.8%−83.2
Q4 FY2017Dec 31, 2017-199.4%−123.1
Q3 FY2017Sep 30, 2017-53.2%−2.6
Q2 FY2017Jun 30, 2017-233.8%−201.8
Q1 FY2017Mar 31, 2017-130.6%−58.2
Q4 FY2016Dec 31, 2016-76.2%–
Q3 FY2016Sep 30, 2016-50.6%–
Q2 FY2016Jun 30, 2016-32.0%–
Q1 FY2016Mar 31, 2016-72.4%–

More Soligenix figures

See a number that looks wrong?